Pathological Complete Response in Locally Advanced Breast Cancer after Neoadjuvant Chemotherapy: Survival Outcome and Its Relevance as a Surrogate End Point
Background Pathological complete response (pCR) to neoadjuvant chemotherapy has emerged as a reliable surrogate marker for improved survival in breast cancer (BC), but its role as a surrogate end point is still controversial. Aims and Objectives The aim of the study is to investigate the clinical c...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-07-01
|
| Colección: | South Asian Journal of Cancer |
| Materias: | |
| Acceso en línea: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721238 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|